Aurobindo Pharma sets its sights on a USD 200 million revenue target from its TheraNym biologics venture by 2032
GLP-1 drug demand is reshaping global pharma economics, as Eli Lilly raised its 2026 sales in its obesity and diabetes portfolio
Alembic Pharma started FY27 with a strong first quarter. The company reported healthy growth in profit and revenue. Its performance was supported by new product launches, volume growth, and steady execution across key markets.
The dental implant safety framework is under consideration by the Central government as concerns grow over the quality, regulation, and long-term safety of dental implants used across India.
Bike ambulance services will gain regulatory clarity as India drafts new rules to strengthen emergency response systems, the proposal also introduces standards to ensure construction, safety, and functional compliance
MedTech Hub development in India accelerates as a new policy framework and global partnerships reshape the country’s medical technology sector
Biocon has secured a major regulatory milestone with Health Canada's approval for its Autoinjector Pen version of Yesintek. The approval strengthens the company's biosimilar portfolio in North America.
Military medicine now drives a transformative shift in Indian healthcare. India launches its first dedicated academic and operational department for this critical domain
Hyderabad strengthens its healthcare landscape with a dedicated centre focused on diabetic wound care, advanced wound healing, and limb salvage
MedTech Innovation is accelerating in India as Tata Elxsi partners with Sree Chitra Tirunal Institute for Medical Sciences and Technology
.jpg)
, CDSCO.jpg)
